Developement and Evaluation of Serological Assays for COVID-19

NCT04377763 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-02-25

No results posted yet for this study

Summary

The primary objective of the study aims to evaluate serological assays of virus Covid-19.

Conditions

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Marie-Anne RAMEIX-WELTI, MD, PhD · Laboratoire de Microbiologie Hygiène hospitalière, Hôpital Ambroise paré, APHP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-15
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04377763 on ClinicalTrials.gov